drugset / Trial / NCT06398834
Esketamine and Butorphanol for Post-Lobectomy Pain
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Post-thoracotomy pain syndrome (PTPS) affects respiratory function, hindering sputum clearance and ventilation, and represents a significant complication of thoracic surgery. The analgesic effect of esketamine combined with butorphanol in PTPS is still unclear, so this study focused on this aspect.
Timeline
- Start
- 2022-03-01
- Primary completion
- 2023-10-01
- Completion
- 2024-01-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Esketamine | Other / unclassified | 0.3 mg/kg | Intravenous |
| Subject | Esketamine | Other / unclassified | 1.5 mg/kg | Intravenous |
| Background | Butorphanol | Other / unclassified | 0.15 mg/kg | — |
Indications
No indication recorded.